Craniopharyngioma is a rare, noncancerous brain tumor that grows near the pituitary gland and can affect vision, hormone balance, and overall health. Early and accurate diagnosis helps determine the best path forward and supports better management of this challenging condition.

Introduction: Who Should Undergo Diagnostics and When

If you or your child are experiencing symptoms like worsening headaches, changes in vision, unusual fatigue, or excessive thirst and urination, it may be time to seek medical attention. Craniopharyngioma can develop at any age, but it most commonly appears in two age groups: children between 5 and 14 years old, and adults between 50 and 74 years old.^[1][2] Because this tumor grows slowly and can take years before symptoms become obvious, many people don’t realize something is wrong until the tumor has grown large enough to press on nearby structures in the brain.

In children, one of the more noticeable signs can be slower growth compared to siblings or peers. Parents or family members might notice that a child who was once growing normally has suddenly fallen behind in height or weight. This happens because craniopharyngioma can affect the pituitary gland, a small but powerful gland that produces hormones responsible for growth and development.^[2] If a child’s growth seems delayed, or if puberty doesn’t begin when expected, it’s important to consult a healthcare provider.

Adults may experience different symptoms, often related to vision or hormonal imbalances. Because craniopharyngioma usually forms near the optic nerves—the nerves that send visual information from the eyes to the brain—people may notice gradual vision loss, particularly in their peripheral (side) vision. This can happen so slowly that individuals may not realize their sight is fading until it becomes significantly impaired.^[2] Changes in hormone levels can also cause fatigue, weight gain, mood changes, or problems with memory and concentration.

It’s also important to seek medical advice if you experience persistent headaches, especially if they are worse in the morning, or if you have nausea and vomiting that doesn’t seem to have an obvious cause. These symptoms can occur when a craniopharyngioma grows large enough to block the normal flow of cerebrospinal fluid (the liquid that cushions the brain and spinal cord), leading to increased pressure inside the skull—a condition called hydrocephalus.^[2]

Diagnostic Methods: How Craniopharyngioma Is Identified

Diagnosing craniopharyngioma typically begins with a thorough review of your medical history and a discussion of any symptoms you’ve been experiencing. Your doctor will want to know when symptoms started, how they’ve progressed, and whether anything makes them better or worse. This conversation helps the healthcare team understand which parts of the body might be affected and guides the choice of diagnostic tests.^[13]

Neurological Examination

A neurological exam is one of the first steps in diagnosing craniopharyngioma. During this exam, a healthcare professional checks your vision, hearing, balance, coordination, reflexes, and—in children—growth and development patterns. The doctor may also assess memory, behavior, and personality, as changes in these areas can indicate that a tumor is affecting certain parts of the brain.^[13] Because craniopharyngiomas often grow near the optic nerves and pituitary gland, problems with vision or hormone function are common clues that something is wrong.

Blood Tests

Blood tests play a crucial role in the diagnosis of craniopharyngioma because they can reveal whether the tumor is interfering with hormone production. The pituitary gland controls many hormones that regulate growth, metabolism, reproductive function, and response to stress. When a craniopharyngioma presses on or damages the pituitary gland, hormone levels in the blood can become abnormal.^[13] For example, blood tests might show low levels of growth hormone (which affects growth and energy), thyroid hormone (which controls metabolism), or cortisol (which helps the body respond to stress). These hormone abnormalities provide important information about how the tumor is affecting the body.

Imaging Tests

Imaging tests are the most important tools for actually seeing the craniopharyngioma and understanding its size, shape, and location. These tests create detailed pictures of the brain and allow doctors to visualize the tumor and nearby structures.^[13]

Magnetic resonance imaging (MRI) is the preferred imaging method for diagnosing craniopharyngioma. An MRI uses powerful magnets and radio waves to create highly detailed images of soft tissues in the brain. It can show the exact location of the tumor, whether it is solid or filled with fluid, and how close it is to critical structures like the pituitary gland, hypothalamus, and optic nerves. MRI scans are particularly good at distinguishing craniopharyngioma from other types of brain tumors.^[13]

Computed tomography (CT) scans may also be used, especially if an MRI is not available or if there are concerns about calcifications—deposits of calcium that sometimes appear in craniopharyngiomas. CT scans use X-rays to create cross-sectional images of the brain. While not as detailed as MRI for soft tissue, CT scans can be helpful in identifying the presence of calcium, which is more common in one subtype of craniopharyngioma called the adamantinomatous type.^[13]

In some cases, doctors may also use X-rays to get a quick initial look at the skull and brain, although more advanced imaging like MRI or CT is usually needed for a definitive diagnosis.^[13]

Eye Examinations

Because craniopharyngiomas often affect the optic nerves, a comprehensive eye examination is an important part of the diagnostic process. An eye doctor (ophthalmologist or neuro-ophthalmologist) will test your vision and examine the optic nerves to see if there is any damage or swelling. Loss of peripheral vision is a common finding in people with craniopharyngioma, and documenting the extent of vision loss helps doctors understand how much the tumor is affecting the nerves. Eye exams are also used to monitor vision throughout treatment and recovery.^[2]

Biopsy

In certain situations, a biopsy may be performed to confirm the diagnosis. A biopsy involves removing a small sample of tumor tissue so it can be examined under a microscope by a specialist called a pathologist. The pathologist can determine the exact type of craniopharyngioma and rule out other conditions. However, because craniopharyngiomas are located in a delicate area of the brain, biopsies are not always necessary—especially if imaging and other tests strongly suggest the diagnosis.^[13]

Distinguishing Craniopharyngioma from Other Conditions

One of the challenges in diagnosing craniopharyngioma is that its symptoms can be similar to those caused by other brain tumors or medical conditions. For example, pituitary adenomas (another type of benign tumor) can also affect hormone levels and vision, but they arise directly from the pituitary gland itself rather than from nearby tissue. Craniopharyngiomas are generally more aggressive in their growth pattern than pituitary adenomas, even though both are noncancerous.^[2] Imaging tests and careful examination of symptoms help doctors tell these conditions apart.

Other conditions that might cause similar symptoms include infections, inflammatory diseases, or other types of brain tumors. This is why a combination of neurological exams, blood tests, imaging, and sometimes biopsy is necessary to reach an accurate diagnosis.

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or approaches to managing craniopharyngioma. Participating in a clinical trial can provide access to cutting-edge therapies and contribute to scientific knowledge that may help future patients. However, not everyone with craniopharyngioma is eligible for every trial. Researchers use specific diagnostic tests and criteria to determine who can participate, ensuring that the trial is safe and that the results will be meaningful.^[3]

Imaging and Tumor Characteristics

Most clinical trials require detailed imaging studies—usually MRI scans—to confirm the diagnosis of craniopharyngioma and to measure the size and location of the tumor. Researchers need to know whether the tumor is newly diagnosed or has come back after previous treatment (a recurrence). Some trials are designed specifically for people with recurrent tumors, while others focus on newly diagnosed cases.^[10]

Imaging also helps determine whether the tumor can be safely treated with the therapy being studied. For example, some clinical trials test targeted drugs that work only on tumors with specific genetic changes. In these cases, researchers may require additional testing to confirm that the tumor has the right genetic mutation.^[10]

Genetic and Molecular Testing

Recent advances in understanding craniopharyngioma have revealed that there are two main subtypes: adamantinomatous and papillary. These subtypes have different genetic characteristics and may respond differently to treatment. The papillary subtype, which is more common in adults, often has a mutation in a gene called BRAF V600E.^[10] Clinical trials testing targeted therapies—such as the combination of vemurafenib (Zelboraf) and cobimetinib (Cotellic)—require genetic testing to confirm that the tumor carries this mutation. This type of testing is usually done on a biopsy sample or on tissue removed during surgery.

Genetic testing is becoming an increasingly important part of the diagnostic process, not only for clinical trial enrollment but also for guiding standard treatment decisions. Knowing the genetic profile of a craniopharyngioma can help doctors predict how the tumor might behave and choose the most effective therapies.^[10]

Hormone and Endocrine Function Tests

Because craniopharyngiomas often cause hormonal imbalances, clinical trials may require baseline blood tests to measure hormone levels before treatment begins. These tests help researchers understand how the tumor is affecting the endocrine system and allow them to monitor changes during the trial. For example, trials might measure levels of growth hormone, thyroid hormone, cortisol, and sex hormones. Participants may also undergo additional endocrine testing throughout the trial to assess how the treatment is impacting hormone function.^[2]

Vision and Neurological Assessments

Many clinical trials include detailed vision testing and neurological exams as part of the qualification process. These assessments provide a baseline against which researchers can measure any improvements or side effects that occur during treatment. For instance, if a trial is testing a new drug or surgical technique, researchers need to know whether it helps preserve or restore vision, or whether it causes any new neurological problems.^[13]

Performance Status and Overall Health

Clinical trials often have specific criteria regarding a participant’s overall health and ability to perform daily activities—something called performance status. This is usually assessed using standardized scales that measure factors like energy level, ability to work, and need for assistance with daily tasks. Trials may exclude people who are very ill or have other serious medical conditions, as these factors can affect both safety and the ability to interpret trial results.^[3]

Before enrolling in a clinical trial, participants typically undergo a comprehensive evaluation that includes all of the tests described above, as well as a review of their medical history, current medications, and any previous treatments they’ve received for craniopharyngioma. This thorough assessment ensures that the trial is a good fit for the participant and that the research can be conducted safely and effectively.